Literature DB >> 7713312

Biological effects of encapsulated insulin on transfected Chinese hamster ovary cells.

M Roques1, G Crémel, D Aunis, P Hubert.   

Abstract

Oral administration of insulin incorporated into the wall of isobutylcyanoacrylate nanocapsule to diabetic rats induces a long-lasting normalization of their fasting glycaemia. In this study, we examined the biological action of encapsulated insulin on DNA and glycogen syntheses in Chinese hamster ovary cells transfected with the human insulin receptor gene. In the 10(-11) mol/l-10(-9) mol/l concentration range, encapsulated insulin elicited responses comparable to those induced by native insulin: at 10(-9) mol/l, the rates of glycogen and DNA synthesis were enhanced by factors 3 and 2.5, respectively. Encapsulated insulin at 10(-7) mol/l evoked receptor desensitization although it did not induce receptor down-regulation and did not alter receptor recycling for up to 6 h. Chloroquine decreased the action of native insulin on glycogen synthesis, but did not affect the dose-response characteristics of encapsulated insulin. Acid-washing of the cells after 1 h of stimulation decreased maximal insulin responsiveness and provoked a dose response curve for encapsulated insulin similar to that of the native hormone. Direct measurement of effective insulin binding activity showed that encapsulated insulin (at 10(-8) and 10(-7) mol/l) was withdrawn from the incubation medium 5-8 times less efficiently than native insulin. These data are in agreement with previous results showing that the polymeric wall protects encapsulated insulin from degradation. Persistence of intact encapsulated insulin inside and outside the cell may result in modifying signalling events and thus be responsible for the observed cellular desensitization.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7713312     DOI: 10.1007/bf00400092

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  17 in total

1.  The preparation and enzymatic hydrolysis of reduced and S-carboxymethylated proteins.

Authors:  A M CRESTFIELD; S MOORE; W H STEIN
Journal:  J Biol Chem       Date:  1963-02       Impact factor: 5.157

2.  The effect of site of administration in the gastrointestinal tract on the absorption of insulin from nanocapsules in diabetic rats.

Authors:  C Michel; M Aprahamian; L Defontaine; P Couvreur; C Damgé
Journal:  J Pharm Pharmacol       Date:  1991-01       Impact factor: 3.765

3.  The two isotypes of the human insulin receptor (HIR-A and HIR-B) follow different internalization kinetics.

Authors:  B Vogt; J M Carrascosa; B Ermel; A Ullrich; H U Häring
Journal:  Biochem Biophys Res Commun       Date:  1991-06-28       Impact factor: 3.575

Review 4.  Alternative delivery systems for peptides and proteins as drugs.

Authors:  D A Eppstein; J P Longenecker
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1988       Impact factor: 4.889

5.  Biphasic responses, quantal signals and cellular behaviour.

Authors:  A D Robertson; J F Grutsch
Journal:  J Theor Biol       Date:  1987-03-07       Impact factor: 2.691

6.  Toxicity of polyalkylcyanoacrylate nanoparticles I: Free nanoparticles.

Authors:  B Kante; P Couvreur; G Dubois-Krack; C De Meester; P Guiot; M Roland; M Mercier; P Speiser
Journal:  J Pharm Sci       Date:  1982-07       Impact factor: 3.534

7.  Biohybrid artificial pancreas: long-term implantation studies in diabetic, pancreatectomized dogs.

Authors:  S J Sullivan; T Maki; K M Borland; M D Mahoney; B A Solomon; T E Muller; A P Monaco; W L Chick
Journal:  Science       Date:  1991-05-03       Impact factor: 47.728

8.  Degradation of poly (isobutyl cyanoacrylate) nanoparticles.

Authors:  V Lenaerts; P Couvreur; D Christiaens-Leyh; E Joiris; M Roland; B Rollman; P Speiser
Journal:  Biomaterials       Date:  1984-03       Impact factor: 12.479

9.  Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose.

Authors:  L Ellis; E Clauser; D O Morgan; M Edery; R A Roth; W J Rutter
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

10.  New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier.

Authors:  C Damgé; C Michel; M Aprahamian; P Couvreur
Journal:  Diabetes       Date:  1988-02       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.